Neoadjuvant Immunotherapy for Regional Metastatic Melanoma: A Systemic Review and Meta-analysis

Neoadjuvant immunotherapy has emerged as a potential solution to improve outcomes for patients with advanced resectable melanoma, particularly in the head and neck region, where the disease is prevalent. Despite advances in adjuvant immunotherapy, locally advanced melanoma continues to pose significant morbidity and mortality challenges. This review aims to evaluate the effectiveness of neoadjuvant immunotherapy for stage III locally metastatic melanoma, considering its impact on pathological response and adverse events.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: 253 Source Type: research